Subclavian revascularization. A quarter century experience.
| Autor: | Edwards WH Jr; Department of Surgery, St. Thomas Hospital, Nashville, Tennessee., Tapper SS, Edwards WH Sr, Mulherin JL Jr, Martin RS 3rd, Jenkins JM |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of surgery [Ann Surg] 1994 Jun; Vol. 219 (6), pp. 673-7; discussion 677-8. |
| DOI: | 10.1097/00000658-199406000-00010 |
| Abstrakt: | Objective: Twenty-five years of experience with subclavian revascularizations were reviewed to determine the long-term patency rates of different extrathoracic approaches. Summary Background Data: Although it is generally agreed that proximal subclavian stenosis should be treated by an extrathoracic route whenever possible, the optimum procedure is debated. Alternatives include subclavian carotid bypass, subclavian-to-subclavian or axillo-axillary bypasses, and the authors' preferred technique of subclavian carotid transposition (SCT). Methods: Records were researched for the past 25 years in a single specialty surgical clinic for extrathoracic subclavian revascularizations. One hundred ninety such procedures were identified, and hospital charts and office medical records were reviewed for procedure, preoperative symptoms, blood pressure differentials, and postoperative complications. Patency was determined by physical examination, differential blood pressures, Doppler spectral analysis, duplex examinations, and arteriography. Results: Bypass procedures were used infrequently, and although the results are reported, they are excluded from any analysis. Subclavian carotid transposition was used in 178 procedures. All anastomoses were found to be patient at follow-up, except for one, which failed at 26 months. Mean follow-up was 46 months, with five patients lost to follow-up. Overall mortality rate was 2.2%, with the mortality falling to 1.1% if only subclavian carotid transposition patients are included. Conclusions: Subclavian carotid transposition should be the treatment of choice for routine subclavian carotid occlusive disease because of its exceptional long-term patency and low morbidity. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|